The effects of heroin on prolactin levels in male rhesus monkeys: Use of cumulative-dosing procedures

Psychoneuroendocrinology

Volumn 27, Issue 3, 2002, Pages 319-336

  Bowen, Carrie A ^a   Stevens Negus, S ^a   Kelly, Maureen ^a   Mello, Nancy K ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Cumulative dose; Heroin; Prolactin; Quadazocine; Rhesus monkey; Single dose

Indexed keywords

DIAMORPHINE; MU OPIATE RECEPTOR; MU OPIATE RECEPTOR AGONIST; MU OPIATE RECEPTOR ANTAGONIST; PROLACTIN; QUADAZOCINE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DOSE TIME EFFECT RELATION; DRUG ANTAGONISM; DRUG EFFECT; MALE; NONHUMAN; PRIORITY JOURNAL; PROLACTIN BLOOD LEVEL; RHESUS MONKEY;

ANIMALS; AZOCINES; DOSE-RESPONSE RELATIONSHIP, DRUG; HEROIN; INJECTIONS, INTRAVENOUS; MACACA MULATTA; MALE; NARCOTIC ANTAGONISTS; NARCOTICS; PITUITARY GLAND, ANTERIOR; RECEPTORS, OPIOID, MU;

EID: 0036162288     PISSN: 03064530     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4530(01)00053-1     Document Type: Article

References (69)

1. Opioid components of the clockwork that governs luteinizing hormone and prolactin release in male rats
2. Regulation of the tuberoinfundibular and nigrostriatal systems: Evidence for different kinds of dopaminergic neurons in the brain
3. Studies on the accessibility of prolactin and growth hormone to brain: Effect of opiate agonists on hormone levels in serial, simultaneous plasma and cerebrospinal fluid samples in the rhesus monkey
4. Dopamine: A prolactin-inhibiting hormone
5. Behavioral effects of selected opiates and phencyclidine in the nondependent and cyclazocine-dependent rhesus monkey
6. A procedure for rapid evaluation of the discriminative stimulus effects of drugs
7. The study of drugs with operant techniques
8. Discriminative stimulus effects of the nonpeptidic delta-opioid agonist SNC80 in rhesus monkeys
9. Apparent pA2 analysis on the respiratory depressant effects of alfentanil, etonitazene, ethylketocyclazocine (EKC) and Mr2033 in rhesus monkeys
10. Apparent efficacy of k-opioid receptor ligands on serum prolactin levels in rhesus monkeys
11. Effects of E-2078, a stable dynorphin A(1-8) analog, on sedation and serum prolactin levels in rhesus monkeys
12. Effects of systemically administered dynorphin A(1-17) in rhesus monkeys
13. Suppression of pulsatile luteinizing hormone and testosterone secretion during short term food restriction in the adult male rhesus monkey (Mucaca mulatta)
14. Effects of heroin addiction on thyrotrophin, thyroid hormones and prolactin secretion in men
15. Differential effects of opiate peptides and alkaloids on anterior pituitary hormone secretion
16. Comparison of dopamine synthesis regulation in the terminals of nigrostriatal, mesolimbic, tuberoinfundibular and tuberohypophyseal neurons
17. Disruption of 5-hydroxytryptaminergic neuronal functions blocks the action of morphine on tuberoinfundibular dopaminergic neurons
18. Kappa opioids in rhesus monkeys. II. Analysis of the antagonistic actions of quadazocine and beta-funaltrexamine
19. Effects of heroin and naltrexone on plasma prolactin levels in man
20. Phencyclidine sedation as a technique for handling rhesus monkeys: Effects on LH, GH, and prolactin secretion
21. Interaction of opioid peptide-containing terminals with dopaminergic perikarya in the rat hypothalamus
22. Diurnal variation in fentanyl-induced hormone responses and side effects
23. Daily modifications of 3H-naloxone binding sites in the rat brain: A quantitative autoradiographic study
24. Opioid effects on plasma concentrations of luteinizing hormone and prolactin in the adult male rhesus monkey
25. The effects of opiate agonist and antagonist on serum prolactin in primates: Possible role for endorphins in prolactin regulation
26. Effects of levorphanol and several kappa-selective opioids on respiration and behavior in rhesus monkeys
27. Respiratory effects of xanthines and adenosine analogs in rhesus monkeys
28. Evidence from opiate binding studies that heroin acts through its metabolites
29. Opiate receptor subtype involvement in the stimulation of prolactin release by beta-endorphin in female rats
30. Circadian variations in β-endorphin concentrations in pituitary and some brain nuclei of the adult male rat
31. Anatomy of the CNS opioid systems
32. Recent advances in molecular recognition and signal transduction of active peptides: Receptors for opioid peptides
33. Relationship between the discriminative stimulus effects and plasma concentrations of intramuscular cocaine in rhesus monkeys
34. Effects of specific activation of mu-, delta- and kappa-opioid receptors on the secretion of luteinizing hormone and prolactin in the ovariectomized rat
35. Stress-induced changes in plasma, pituitary and hypothalamic immunoreactive β-endorphin: Effects of diurnal variation, adrenalectomy, corticosteroids, and opioid agonists and antagonists
36. Opioid-receptor mRNA expression in the rat CNS: Anatomical and functional implications
37. Anatomy of CNS opioid receptors
38. Antagonism of delta(2)-opioid receptors by naltrindole-5′-isothiocyanate attenuates heroin self-administration but not antinociception in rats
39. Effects of naloxone on diurnal rhythms in mood and endocrine function: A dose-response study in man
40. Dopaminergic inhibition of prolactin synthesis and prolactin messenger RNA accumulation in cultured pituitary cells
41. Naltrexone effects on pituitary and gonadal hormones in male and female rhesus monkeys
42. Acute effects of nalmefene on LH, prolactin, and testosterone in male rhesus monkeys
43. Circadian rhythm in rat brain opiate receptor
44. Effects of opioid agonists selective for mu, kappa and delta opioid receptors on schedule-controlled responding in rhesus monkeys: Antagonism by quadazocine
45. Opioid antinociception in ovariectomized monkeys: Comparison with antinociception in males and effects of estradiol replacement
46. 33P in situ hybridization study
47. Evaluation of the effects induced by four opiate drugs, with different affinities to opioid receptor subtypes, on anterior pituitary LH, TSH, PRL and GH secretion and on cortisol secretion in normal men
48. The heroin metabolite, 6-monoacetylmorphine, activates delta opioid receptors to produce antinociception in Swiss-Webster mice
49. Heroin acts on different opioid receptors than morphine in Swiss-Webster and ICR mice to produce antinociception
50. Gonadal function in male heroin and methadone addicts
51. Naloxone lowers plasma-prolactin in man
52. Discrete versus cumulative dosing in dose-response discrimination studies
53. μ Opioid receptor-mediated G-protein activation by heroin metabolites: Evidence for greater efficacy of 6-monoacetylmorphine compared to morphine
54. The effects of opiate agonists on growth hormone and prolactin release in rats
55. Comparing single and cumulative dosing procedures in human triazolam discriminators
56. Participation of the opioid system in the regulation of prolactin secretion in androgenized rats: Effect of ovarian steroids
57. Prolactin and thryotropin pituitary response to thryrotropin releasing hormone in young female heroin addicts
58. Effects of cocaine and related drugs in nonhuman primates. II. Stimulant effects on schedule-controlled behavior
59. The effects of spiradoline (U-62066E), a kappa-opioid receptor agonist, on neuroendocrine function in man
60. Comparison of the duration of action of nalmefene and naloxone on the hypothalamic-pituitary axis of the rhesus monkey
61. β-Endorphin-induced decrease in hypothalamic dopamine turnover
62. Hormonal and other effects of naltrexone in normal men
63. Effects of central administration of highly selective opioid mu-, delta- and kappa-receptor agonists on plasma luteinizing hormone (LH), prolactin, and the estrogen-induced LH surge in ovariectomized ewes
64. Multiple opioid receptor profile in vitro and activity in vivo of the potent opioid antagonist WIN 44,441-3
65. The pharmacologic effects of heroin in relationship to its rate of biotransformation
66. Dopaminergic and serotonergic involvement in opiate-induced prolactin release in monkeys
67. Reduction by β-endorphin of efflux of dopamine and DOPAC from superfused medial basal hypothalamus
68. Activation of delta-opiate receptor simultaneously stimulates ACTH beta-endorphin and prolactin release
69. Prolactin in human reproduction